The American Thoracic Society (ATS) has officially unveiled ATS Now, a cutting-edge, on-demand video learning platform designed to reshape how pulmonary, critical care, and sleep medicine professionals engage with clinical education. By synthesizing high-level conference highlights, expert-led webinars, and specialized research presentations into a single, AI-driven interface, the organization aims to bridge the gap between rapidly evolving medical breakthroughs and the demanding schedules of frontline clinicians.
Marketed by the society as “Netflix for pulmonologists,” the platform represents a significant technological leap for the ATS, signaling a departure from traditional, siloed educational models toward a personalized, digital-first strategy.
Main Facts: What is ATS Now?
ATS Now functions as a centralized digital repository for the most critical educational assets within the respiratory healthcare sector. The platform is engineered to serve a global audience, catering to the needs of pulmonologists, critical care specialists, respiratory therapists, and researchers who require immediate access to the latest clinical guidelines and international research.
Core Features:
- AI-Powered Personalization: The platform utilizes sophisticated algorithms to analyze user behavior and professional interests, offering tailored content recommendations that evolve alongside the clinician’s specialty and practice focus.
- On-Demand Accessibility: Removing the temporal and geographic constraints of physical conferences, ATS Now allows users to stream sessions at their convenience, whether during a commute or in between clinical rounds.
- Curated Educational Streams: The content is categorized by clinical relevance, including annual meeting highlights, deep-dive expert presentations, and focused topical modules.
- Cross-Disciplinary Integration: The platform encompasses the full breadth of the ATS mission, covering respiratory health, critical care medicine, and the complexities of sleep disorders.
Chronology: The Evolution of ATS Digital Strategy
The launch of ATS Now is not an isolated development but rather the culmination of a multi-year digital transformation strategy at the American Thoracic Society.
- Pre-2020: ATS relied heavily on in-person international conferences and print-based publications as the primary vehicles for disseminating clinical knowledge.
- 2020–2022 (The Pivot): The global pandemic necessitated a sudden, massive shift toward virtual learning. During this period, the ATS successfully experimented with webinar series and virtual poster sessions, establishing a proof-of-concept for remote education.
- 2023–2024 (Development Phase): Recognizing that virtual engagement was no longer a temporary fix but a permanent professional expectation, the society began development on a unified, high-performance platform. The goal was to consolidate disparate educational resources into a user-friendly interface.
- 2025 (The Launch): ATS Now enters the market, positioning itself as a premier educational tool for the global pulmonary community.
- The Roadmap Ahead: The platform is scheduled to integrate further AI enhancements by 2026, aimed at predictive learning—where the system identifies gaps in a clinician’s knowledge base and suggests specific modules to close those gaps.
Supporting Data and Access Tiers
The sustainability and accessibility of ATS Now are structured through a tiered pricing model, ensuring that the platform remains viable while supporting a diverse user base, ranging from medical students to established consultants.
Access Structure:
- ATS 2026 International Conference Attendees: As a value-added benefit, those registered for the 2026 conference will receive complimentary access to the platform, including high-demand sessions like the “Clinical-Year-in-Review,” through December 31, 2026.
- ATS Members: For members who are unable to attend the international conference in person, a subscription fee of $50 USD provides full access to the content library.
- Non-Member Trainees: In an effort to foster the next generation of respiratory specialists, trainees who are not members of the ATS can access the platform for $200 USD.
- Non-Member Professionals: Practicing clinicians and researchers who hold no current ATS affiliation may purchase access for $300 USD.
These price points are designed to be competitive with other continuing medical education (CME) platforms, while offering the added prestige and peer-reviewed rigor associated with the American Thoracic Society.
Official Responses and Strategic Vision
The leadership at the American Thoracic Society has been vocal about the necessity of this transition. For the modern clinician, the "information overload" associated with medical research is a significant barrier to staying current.
"ATS Now is like Netflix for pulmonologists, giving our members a truly personalized and flexible way to stay connected with high-value educational content," said Raed Dweik, MD, MBA, ATSF, President of the ATS.
Dr. Dweik emphasized that the platform is not merely a video library but a vital resource for lifelong learning. By mimicking the intuitive, recommendation-based interface of consumer streaming services, the ATS hopes to lower the "friction" associated with clinical research, making it easier for practitioners to integrate new findings into their daily patient care workflows.
Furthermore, the society’s executive committee noted that the platform serves a secondary purpose: global health equity. By providing digital access to content that was previously locked behind physical barriers (travel costs, conference registration fees, and time off), ATS Now ensures that clinicians in resource-limited or geographically isolated settings have access to the same high-level educational material as those in major academic medical centers.
Implications for the Pulmonary and Critical Care Community
The introduction of ATS Now marks a shift in how medical societies justify their value to members. In an era where information is abundant but quality is often difficult to verify, the ATS is doubling down on its role as a curator of clinical truth.
Impact on Clinical Practice
The primary implication for the pulmonary and critical care community is the acceleration of "evidence-to-bedside" translation. When a breakthrough in ventilator management or a new therapeutic protocol for idiopathic pulmonary fibrosis is presented at an international meeting, clinicians can now access that information within days—or even hours—of the initial presentation. This reduces the lag time between the emergence of new research and its implementation in clinical practice.
Redefining Medical Education
For residents and fellows, the platform offers a structured way to navigate the complexities of pulmonary medicine. Rather than scrolling through disparate online search results, trainees can follow curated learning paths on ATS Now. This supports the evolving educational requirements of clinicians who must balance their board certification requirements with the hands-on demands of a clinical environment.
The Future of Medical Conferences
While the platform provides a digital alternative, it also creates a symbiotic relationship with physical conferences. By showcasing the "best of" the conference on ATS Now, the society is incentivizing future attendance. It creates a "teaser" effect where practitioners can see the value of in-person networking while ensuring that those who cannot travel still benefit from the scientific programming.
Technological Advancements in CME
The move toward AI-driven personalization sets a new benchmark for medical societies. As the platform matures, it will likely begin to offer personalized CME credit tracking, automated notifications for new research in specific niches (e.g., sleep apnea or COPD), and interactive quizzes to reinforce learning.
Conclusion: A New Standard for Digital Professional Development
The launch of ATS Now represents more than just a software update; it is a fundamental re-imagining of how medical societies support their constituents. By embracing the "on-demand" culture that dominates the consumer world, the American Thoracic Society is acknowledging that the modern physician’s life is fast-paced, mobile, and increasingly digital.
As the society continues to refine the platform, it is poised to become the definitive digital destination for respiratory healthcare professionals worldwide. Whether a clinician is looking for a quick review of a clinical guideline before a shift or a deep dive into emerging respiratory research, ATS Now offers a streamlined, personalized, and authoritative solution.
The success of this initiative will be measured not just by the number of subscribers, but by the tangible improvements in patient care as clinicians become better informed, more efficiently educated, and more connected to the global respiratory community. For the ATS, the future of medicine is not just in the clinic or the lab—it is in the palm of every practitioner’s hand.
